Gestodene + Ethinylestradiol
Harmonet is a combined hormonal contraceptive pill ("the Pill") for use in preventing pregnancy.
It contains two types of female sex hormones: estrogen and progestogen. These hormones prevent pregnancy by acting in three ways: preventing the release of an egg from the ovaries; thickening the mucus in the cervix, making it harder for sperm to penetrate the uterus; preventing the thickening of the uterine lining so that a fertilized egg cannot develop in it.
Harmonet should be taken every day for 21 days (1 tablet), followed by 7 days without taking a tablet.
Harmonet does not protect against sexually transmitted infections, such as chlamydia or HIV. Only condoms protect against these infections.
Before starting to take Harmonet, you should read the information about blood clots (thrombosis) in section 2. It is particularly important to read about the symptoms of blood clots (see section 2 "BLOOD CLOTS").
It is essential to understand the benefits and risks of taking the Pill before starting to take it or deciding to continue taking it. Although the Pill is suitable for most healthy women, it is not suitable for all of them.
You should inform your doctor if you have any diseases or risk factors mentioned in this leaflet.
Your doctor will ask you some questions about your health and the health of your close relatives and measure your blood pressure, and may also perform other examinations, such as a breast examination.
You should not take Harmonet if you have any of the conditions listed below. If you have any of the conditions listed below, you should inform your doctor. Your doctor will discuss with you which other contraceptive method will be more suitable for you.
When should you contact your doctor?
You should contact your doctor immediately:
If these symptoms occur or worsen while taking Harmonet, you should also tell your doctor.
Women taking the Pill are strongly advised to stop smoking.
Smoking increases the risk of serious cardiovascular side effects. This risk increases with age and the number of cigarettes smoked and is significant in women over 35 years of age.
Taking combined hormonal contraceptives, such as Harmonet, is associated with an increased risk of blood clots compared to not taking them. In rare cases, a blood clot can block a blood vessel and cause serious complications.
Blood clots can occur
You should contact your doctor immediately if you notice any of the following symptoms.
Are you experiencing any of these symptoms?
Why is the patient likely to be suffering from
Deep vein thrombosis
Pulmonary embolism
| |
Symptoms usually occur in one eye:
| Retinal vein thrombosis (blood clot in the eye) |
| Heart attack |
| Stroke |
In some cases, the symptoms of a stroke may be temporary with almost immediate and complete recovery, however, you should contact your doctor immediately, as you may be at risk of having another stroke. | |
| Blood clots blocking other blood vessels |
The risk of blood clots in a vein is highest during the first year of taking combined hormonal contraceptives for the first time. The risk may also be higher when restarting combined hormonal contraceptives (the same or a different product) after a break of 4 weeks or more.
After the first year, the risk decreases, but it is always higher than when not taking combined hormonal contraceptives.
If you stop taking Harmonet, the risk of blood clots returns to normal within a few weeks.
The risk of blood clots in a vein is small, but some factors can increase this risk. The risk is higher:
The risk of blood clots in a vein increases with the number of risk factors present in a woman.
Long-haul flights (>4 hours) may temporarily increase the risk of blood clots, especially if you have another risk factor.
It is essential to tell your doctor if any of these risk factors apply to you, even if you are not sure. Your doctor may decide to stop Harmonet.
You should inform your doctor if any of these conditions change while taking Harmonet, e.g. if someone in your close family is diagnosed with a blood clot without a known cause or if you gain weight significantly.
Similarly to blood clots in veins, blood clots in arteries can cause serious complications, such as a heart attack or stroke.
It is essential to note that the risk of heart attack or stroke associated with Harmonet is very small, but it may increase:
If you have more than one of these conditions or if any of them are severe, the risk of blood clots may be even higher.
You should inform your doctor if any of these conditions change while taking Harmonet, e.g. if you start smoking, someone in your close family is diagnosed with a blood clot without a known cause, or if you gain weight significantly.
Taking the Pill for a long time reduces the risk of ovarian and endometrial cancer. However, it appears to slightly increase the risk of cervical cancer– although this may be due to sexual behavior rather than the Pill. The most important risk factor for cervical cancer is persistent human papillomavirus infection.
All women should have regular cervical smears.
If you have (or have had) breast cancer, you should not take the Pill.
The Pill slightly increases the risk of breast cancer. This risk increases with the duration of Pill use but decreases within 10 years of stopping Pill use. Breast cancer is rare in women under 40 years of age, so the risk of additional breast cancer cases in women currently or recently taking the Pill is small.
You should contact your doctor as soon as possible if you notice any changes in your breasts, such as dimpling of the skin, changes in the nipples, or any lumps that can be seen or felt.
Very rarely, taking the Pill has also been linked to certain types of liver cancerin women taking it for a long time.
Very rarely, taking the Pill has also been linked to liver disease, such as jaundice and non-cancerous liver tumors.
Early detection of liver cell damage allows for prompt withdrawal of the Pill, which reduces the harmful effect of the Pill on the liver. If liver cell damage is detected, you should stop taking the Pill, use another method of contraception, and consult your doctor.
It may be necessary not to take the Pill until liver function disorders have resolved.
If you wear contact lenses, you may experience discomfort or even intolerance while taking the Pill. If you experience more serious eye problems, you should stop taking the Pill and contact your doctor immediately.
While taking the Pill, your blood pressure may increase. If you have ever had high blood pressure, you may need to use another method of contraception. If your doctor prescribes the Pill, you should have your blood pressure checked regularly, and if it increases significantly, you should stop taking the Pill and use another method of contraception (see also section "Do not take Harmonet if you have any of the following conditions").
If you experience migraine or headache, which you have not had before, the Pill may not be suitable for you. In this case, you should stop taking the Pill and contact your doctor.
If you have ever had problems with glucose tolerance or diabetes, you should tell your doctor, as close monitoring may be necessary (see also section "Do not take Harmonet if you have any of the following conditions").
In a small number of women, taking the Pill can cause changes in blood lipid levels. You should inform your doctor, who may consider prescribing a non-hormonal contraceptive.
If you are being treated for high lipid levels, you will need regular check-ups while taking the Pill.
You may experience irregular bleeding or spotting, especially during the first three months of taking the Pill. If these types of bleeding continue or recur, you should contact your doctor to rule out non-hormonal causes, such as pregnancy or certain diseases. If necessary, your doctor may prescribe a different Pill (see also section "Irregular bleeding between periods should not last long").
If you have never had regular periods or have irregular periods, these conditions may recur while taking the Pill.
If you have irregular periods while taking the Pill, see also section "If you miss a dose of Harmonet".
Some women taking hormonal contraceptives, including Harmonet, have reported depression or low mood. Depression can be severe and sometimes lead to suicidal thoughts. If you experience mood changes or symptoms of depression, you should contact your doctor as soon as possible for further medical advice.
Women with a history of depression should be closely monitored, and if they experience severe symptoms of recurrent depression, they should stop taking the Pill. It may be necessary to use a different type of contraception.
Before prescribing the Pill for the first time, your doctor will take a complete medical history, including a family history, and perform a physical examination. You should have regular cervical smears.
Your next visit should be after three months of taking the Pill. Once a year, you should have a check-up with your doctor, which will be the same as the first examination.
Harmonet is intended for use only in women of childbearing age.
It should not be used by children or postmenopausal women.
You should tell your doctor or pharmacist about all the medicines you are currently taking or have recently taken, including those that are available without a prescription. You should also check the leaflets of all the medicines you are taking to see if they can be used with hormonal contraceptives.
Some medicines may make Harmonet less effective in preventing pregnancy, such as:
If you need to take any of these medicines, it may be necessary to use additional contraception for a certain period. Your doctor or pharmacist will tell you if this is necessary and for how long.
Harmonet may also affect the action of other medicines. Therefore, it is essential to tell your doctor if you are taking the Pill with other medicines.
Taking a medicine called troleandomycin while taking the Pill increases the risk of liver disorders (reduced bile secretion by the liver).
Taking a medicine called flunaryzine while taking the Pill may sometimes cause milk production in the breasts of women who have not recently given birth.
You should not take Harmonet if you have hepatitis C and are taking medicines containing ombitasvir/paritaprevir/ritonavir, dasabuvir, glecaprevir/pibrentasvir, or sofosbuvir/velpatasvir/voxilaprevir, as they may increase liver function test results (increase in liver enzyme alanine aminotransferase).
Your doctor should prescribe a different type of contraception before starting treatment with these medicines.
Harmonet can be taken again after about 2 weeks after the end of treatment. See section "Do not take Harmonet if you have any of the following conditions".
There are no special instructions for taking Harmonet with food and drink.
Before taking any medicine, you should consult your doctor.
You should not take Harmonet if you are pregnant. If you suspect you are pregnant, you should have a pregnancy test to confirm before stopping Harmonet.
There is no evidence that Harmonet causes harm to the fetus if you become pregnant while taking the Pill, but if you become pregnant, you should stop taking Harmonet.
You should not take Harmonet if you are breastfeeding. You should discuss other methods of contraception with your doctor. Breastfeeding does not protect against pregnancy.
Harmonet contains lactose and sucrose. If you have been diagnosed with intolerance to some sugars, you should contact your doctor before taking the Pill.
Harmonet should always be taken as directed by your doctor. If you are unsure, you should contact your doctor.
Harmonet is available in blisters containing 21 tablets. Each tablet is marked with a symbol of the day of the week.
After taking all 21 tablets from the blister pack, there are 7 days without taking tablets. If you took the last tablet from the first pack on a Friday, you should take the first tablet from the next pack on the following Saturday.
Within a few days of taking the last tablet from the blister pack, you will experience withdrawal bleeding, which will be like a period. This bleeding may not have stopped before you start the next pack of tablets.
There is no need to use additional contraception during these 7 days without tablets, as long as the tablets have been taken correctly and the next pack is started on time.
After 7 days without tablets, you should start the next Harmonet blister pack - even if the bleeding has not stopped. You should always start a new pack on time.
As long as Harmonet is taken correctly, each subsequent pack will start on the same day of the week.
You should start taking Harmonet on the first day of your next period. Starting in this way gives you immediate contraceptive protection.
It is also possible to start taking Harmonet between days 2-7 of your period (e.g. starting on a Sunday). In this case, you should use additional contraceptive methods, such as a condom, until you have taken the first 7 tablets correctly.
If the miscarriage or abortion occurred within the first three monthsof pregnancy, your doctor may tell you that you can start taking Harmonet immediately. This means that you will have immediate contraceptive protection.
If the miscarriage or abortion occurred after the third monthof pregnancy, you can start taking Harmonet after 28 days. It is recommended to use additional contraceptive methods, such as a condom, during the first 7 days of taking Harmonet. If you have had sex, you should rule out pregnancy or wait for your next period.
You can start taking Harmonet 28 days after a normal vaginal delivery, provided that you are not breastfeeding and are fully recovered. It is recommended to use additional contraceptive methods during the first 7 days of taking Harmonet.
If you have had sex, you should rule out pregnancy or wait for your first period after childbirth or abortion.
Your doctor will provide further information about contraception.
It is unlikely that taking more than one tablet will cause side effects, but you should contact your doctor as soon as possible.
In case a tablet is missed, follow the instructions below.
If it has been less than 12 hourssince the missed tablet, take the missed tablet as soon as possible. Continue taking the next tablets at the usual time. Contraceptive protection has not been reduced.
If it has been more than 12 hourssince the missed tablet or two or more active tablets have been missed, contraceptive protection may be reduced. Therefore, take only the last missed tablet as soon as possible, which may mean taking two tablets on the same day. Leave the previously missed tablets in the blister pack and continue taking the next tablets as usual. Additionally, use non-hormonal methods of contraception, such as condoms, for the next seven days.
Then, follow these rules:
If the patient has forgotten to take any of the tablets from the blister pack and has not had bleeding during the tablet-free period, this may indicate pregnancy. Before starting to take tablets from the next blister pack, contact your doctor or pharmacist, or take a pregnancy test.
If the patient has started a new blister pack late, they may not be protected against pregnancy. If intercourse has occurred within the last seven days, consult a doctor or pharmacist. Also, use measures such as condoms for seven days.
If vomiting or severe diarrhea occurs, the hormones from the tablet may not have been fully absorbed. Continue taking the tablets at the usual time. Use additional non-hormonal contraception, such as condoms, during the illness and for the next seven days after recovery. If more than 12 hours have passed, follow the instructions from the "Missing a Harmonet Dose" section.
Contact your doctor if gastrointestinal disturbances do not resolve or worsen. The doctor may recommend a different contraceptive method.
Occasionally, withdrawal bleeding may not occur. This may indicate pregnancy, but it is very unlikely if the tablets have been taken correctly. If there is a risk of pregnancy (e.g., due to a missed tablet or taking other medications) before starting the next pack, take a pregnancy test. If the patient is pregnant, stop taking Harmonet and contact a doctor.
If the patient wants to delay the onset of withdrawal bleeding, skip the 7-day break and start taking tablets from a new pack of Harmonet immediately. Withdrawal bleeding can be delayed for any length of time, up to the time all tablets from the new pack have been taken. During this time, breakthrough bleeding or spotting may occur. Regular intake of Harmonet should be resumed after a normal 7-day break.
If the patient has more questions about using this medication, they should talk to a doctor or pharmacist.
Like all medicines, Harmonet can cause side effects, although not everybody gets them. If side effects occur, especially severe and persistent ones or changes in health that the patient considers related to the use of Harmonet, consult a doctor.
Contact a doctor immediately if any of the following symptoms of angioedema occur: swelling of the face, tongue, and/or throat, and/or difficulty swallowing or hives that may cause difficulty breathing (see also "Warnings and Precautions").
Serious side effects related to taking the contraceptive pill have been described in section 2, "The Pill and Thrombosis" and "The Pill and Cancer". If more information is needed, read these sections.
Like all medicines, Harmonet can cause allergic reactions (hypersensitivity). These reactions may include, in very rare cases, hives, sudden swelling of tissues, and severe reactions from the respiratory and cardiovascular systems, such as: decreased blood pressure, dizziness, nausea, and difficulty breathing. If any symptoms of an allergic reaction are noticed, stop taking Harmonet immediately and tell a doctor or go to the nearest hospital.
All women taking combined hormonal contraceptives have an increased risk of developing blood clots in veins (venous thromboembolism) or blood clots in arteries (arterial thrombosis). For detailed information on the various risk factors associated with the use of combined hormonal contraceptives, see section 2, "Important Information Before Taking Harmonet".
Very Common(occurring in more than 1 in 10 women):
Common(occurring in 1 to 10 in 100 women):
Uncommon(occurring in 1 to 10 in 1,000 women):
Rare(occurring in 1 to 10 in 10,000 women):
Very Rare(occurring in less than 1 in 10,000 women):
The risk of developing blood clots may be higher if the patient has other risk factors (see section 2 for more information on risk factors for blood clots and symptoms of blood clots).
Harmonet may also cause inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis) and liver cell damage (e.g., hepatitis, liver function disorders) with an unknown frequency, which cannot be determined from the available data.
Tell a doctor or pharmacist if the patient is concerned that any side effect may be due to Harmonet. If any existing condition worsens while taking Harmonet, also inform a doctor or pharmacist.
Some women may experience unexpected light bleeding or spotting while taking Harmonet, especially during the first few months. Usually, this bleeding is not a cause for concern and will stop after one or two days. Take Harmonet as usual. The condition should resolve after taking the first few packs of Harmonet.
Unexpected bleeding may also occur if the tablets are not taken regularly; therefore, try to take the tablets every day at the same time. Unexpected bleeding may also be caused by taking other medications.
Consult a doctor if bleeding or spotting:
If any side effects occur, including any side effects not listed in the leaflet, tell a doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Reporting side effects will help gather more information on the safety of the medication.
Keep out of sight and reach of children.
Do not use Harmonet after the expiration date stated on the packaging. The expiration date refers to the last day of the given month.
Do not store above 25°C. Store in the outer packaging to protect from light.
Medicines should not be disposed of via wastewater or household waste. Ask a pharmacist how to dispose of unused medicines. This will help protect the environment.
The active substances are gestodene and ethinylestradiol.
Each tablet contains 75 micrograms (0.075 mg) of gestodene and 20 micrograms (0.020 mg) of ethinylestradiol.
The medication also contains:
The tablet core contains: lactose monohydrate, cornstarch, povidone 25, magnesium stearate.
The tablet coating contains: sucrose, povidone 90, macrogol 6000, calcium carbonate, talc, wax E.
Coated tablets.
The tablets are white, round, coated with a shiny surface.
Blister pack with PVC/Al foil in a carton with silica gel as a desiccant.
Each pack of Harmonet contains 1 x 21 or 3 x 21 coated tablets.
A carton sleeve is provided with the packaging.
For more detailed information, contact the marketing authorization holder or parallel importer.
Pfizer SA
Boulevard de la Plaine 17
1050 Brussels
Belgium
Haupt Pharma Münster GmbH
Schleebrüggenkamp 15
48159 Münster
Germany
Pfizer Ireland Pharmaceuticals
Newbridge
Little Connell
Co. Kildare
Ireland
Medezin Sp. z o.o.
Zbąszyńska Street 3
91-342 Łódź
Medezin Sp. z o.o.
Zbąszyńska Street 3
91-342 Łódź
Marketing authorization number in Belgium, the country of export: BE174115
Translation of day-of-the-week symbols on the packaging:
Lu/Ma/Mo – Monday
Ma/Di/Di – Tuesday
Me/Wo/Mi – Wednesday
Je/Do/Do – Thursday
Ve/Vr/Fr – Friday
Sa/Za/Sa – Saturday
Di/Zo/So – Sunday
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.